Objectives: Previously, we have shown in cross-sectional analysis of patients with type 2 diabetes mellitus that the presence of diabetic nephropathy is associated with increased home blood pressure (HBP) variability. We now examine the prognostic significance of HBP variability in substantially the same cohort.

Methods: We performed a prospective cohort study of type 2 diabetes patients. We analyzed 714 patients. Major exclusion criteria are missing data of urinary albumin excretion and newly prescribed or stopped renin-angiotensin system inhibitors during 2-year follow-up. Patients were instructed to perform triplicate morning and evening HBP measurements for 14 consecutive days. We computed day-by-day HBP variability as within-patient standard deviation (SD) and coefficient of variation (CV) of measurements.

Results: During the follow-up period of 2 years, 23 patients progressed to macroalbuminuria. The changing risk of progression to macroalbuminuria with increasing day-by-day variability of morning SBP was better depicted using smoothing spline analyses. Patients with greater SD of morning SBP tended to significantly progress to macroalbuminuria [odds ratio: 5.24 (95% confidence interval: 2.10-13.03; P > 0.001)]. Patients with greater CV of morning SBP also tended to significantly progress to macroalbuminuria [odds ratio: 3.36 (95% confidence interval: 1.39-8.12; P = 0.007)].

Conclusion: Day-by-day variability of morning SBP was proven as an independent predictor for progression to macroalbuminuria in patients with type 2 diabetes.

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000001657DOI Listing

Publication Analysis

Top Keywords

morning sbp
16
day-by-day variability
12
progression macroalbuminuria
12
type diabetes
12
hbp variability
12
patients
9
prognostic significance
8
blood pressure
8
macroalbuminuria patients
8
patients type
8

Similar Publications

Objective: To analyze the relationship between platelet parameters, morning peak blood pressure (MPBP) in hypertensive patients, and angiotensin-converting enzyme (ACE) gene polymorphisms.

Methods: This study included 245 primary hypertensive patients treated between February 2019 and February 2022, who were divided into two groups based on MPBP status: 144 patients with MPBP and 101 without MPBP. Baseline data and early morning fasting blood samples from the antecubital vein were collected.

View Article and Find Full Text PDF

To compare the levels of podocyte damage markers nephrin and podocalyxin in urine samples taken at the time of gestational diabetes mellitus (GDM) diagnosis and at birth. Amniotic fluid podocalyxin (pdx) and nephrin levels were also analyzed to determine whether GDM had an impact on fetal glomeruli. A total of 50 patients, including 24 patients diagnosed with gestational diabetes and 26 healthy pregnant women whose gestational weeks were matched, were included in the study.

View Article and Find Full Text PDF
Article Synopsis
  • Acute hypertension is common in postcraniotomy patients, prompting many to require antihypertensive treatment due to the risk of intracranial hemorrhage.
  • A national survey conducted among neurosurgical residents revealed that most programs set specific systolic blood pressure (SBP) goals post-surgery, primarily aiming for SBP below 140 mm Hg or 160 mm Hg.
  • The most frequently used medications to manage blood pressure were intravenous nicardipine and labetalol, with practices generally consistent until the next morning after surgery.
View Article and Find Full Text PDF
Article Synopsis
  • Hypertension is a known risk factor for atrial fibrillation (AF) and strokes, but there is limited research on AF screening in hypertensive patients and its link to blood pressure levels.
  • A study involving over 4,000 hypertensive patients aged 60 and older in Japan measured their electrocardiograms (ECG) and blood pressure (BP) at home for three months.
  • The study found that 5.8% of participants had undiagnosed AF, with no significant differences in AF detection rates based on different baseline BP categories or the use of antihypertensive medication.
View Article and Find Full Text PDF

Introduction: Cardiovascular disease (CVD) is a leading global cause of morbidity and mortality, with high systolic blood pressure (SBP) identified as a major risk factor. Aspirin (Acetylsalicylic acid-ASA) has been considered for CVD prevention, prompting questions about its optimal use in primary and secondary prevention and the ideal dosing time to maximize its impact on circadian blood pressure rhythms. Previous research suggests a potential benefit of bedtime aspirin dosing in reducing blood pressure, attributed to its effects on the renin-angiotensin-aldosterone system and nitric oxide production.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!